Rapid-Acting Insulin Compositions

Patent No. EP3233108 (titled "Rapid-Acting Insulin Compositions") was filed by ELI Lilly on Dec 9, 2015. The application was issued on Mar 30, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SCORPIODec 30, 2022SAGITTARIUS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3233108

ELI LILLY
Application Number
EP15817678A
Filing Date
Dec 9, 2015
Status
Granted And Under Opposition
Feb 25, 2022
Publication Date
Mar 30, 2022